Literature DB >> 6303226

An immunofluorescence complement-fixation test for detection of human papilloma viruses in various warts and wartlike lesions of epidermodysplasia verruciformis.

T Chorzelski, M Jarzabek-Chorzelska, S Jabłońska, G Orth, G Rzesa.   

Abstract

Comparative studies of indirect immunofluorescence (IF) and IF complement fixation tests were performed in 11 warts induced by various human papilloma viruses (HPV) or wartlike lesions of epidermodysplasia verruciformis. For the detection of HPVs, specific immune sera against HPV1, HPV2, HPV3, HPV5, HPV9 and/or HPV8 were used. The complement-fixation test proved to be as specific as the indirect IF method for the detection of HPVs in the tissues and was superior in clarity of IF readings (no nonspecific IF staining).

Entities:  

Mesh:

Year:  1983        PMID: 6303226     DOI: 10.1007/bf00516556

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  20 in total

1.  LOCALIZATION OF SPECIFIC ANTIGEN IN HUMAN WARTS.

Authors:  E L WALTER; D L WALKER; G A COOPER
Journal:  Arch Pathol       Date:  1965-04

2.  Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis.

Authors:  G Orth; S Jablonska; M Jarzabek-Chorzelska; S Obalek; G Rzesa; M Favre; O Croissant
Journal:  Cancer Res       Date:  1979-03       Impact factor: 12.701

3.  Partial characterization of the proteins of human papilloma viruses (HPV) 1-3.

Authors:  H Pfister; L Gissmann; H zur Hausen
Journal:  Virology       Date:  1977-11       Impact factor: 3.616

4.  Immunological studies in epidermodysplasia verruciformis.

Authors:  S Jablonska; G Orth; M Jarzabek-Chorzelska; G Rzesa; S Obalek; W Glinski; M Favre; O Croissant
Journal:  Bull Cancer       Date:  1978       Impact factor: 1.276

5.  Epidermodysplasia verruciformis versus disseminated verrucae planae: is epidermodysplasia verruciformis a generalized infection with wart virus?

Authors:  S Jablonska; G Orth; M Jarzabek-Chorzelska; G Rzesa; S Obałek; W Glinski; M Favre; O Croissant
Journal:  J Invest Dermatol       Date:  1979-03       Impact factor: 8.551

6.  Capability of complement fixation of pemphigus antibodies in vitro.

Authors:  T Nishikawa; S Kurihara; T Harada; M Sugawara; H Hatano
Journal:  Arch Dermatol Res       Date:  1977-10-27       Impact factor: 3.017

7.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

8.  [Light-microscopic study of classified virus warts (HPV-1 and HPV-4) (author's transl)].

Authors:  E I Grussendorf
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

9.  Identification of papillomaviruses in butchers' warts.

Authors:  G Orth; S Jablonska; M Favre; O Croissant; S Obalek; M Jarzabek-Chorzelska; N Jibard
Journal:  J Invest Dermatol       Date:  1981-02       Impact factor: 8.551

10.  Characterization of a new type of human papillomavirus that causes skin warts.

Authors:  G Orth; M Favre; O Croissant
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

View more
  1 in total

Review 1.  Immunopathology of papillomavirus-induced tumors in different tissues.

Authors:  S Jablonska; G Orth; M A Lutzner
Journal:  Springer Semin Immunopathol       Date:  1982
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.